CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
35.70
+0.18 (0.51%)
May 29, 2026, 4:00 PM EDT - Market closed
CONMED Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,371 | 1,375 | 1,307 | 1,245 | 1,045 | 1,011 | |
Revenue Growth (YoY) | 4.14% | 5.18% | 5.00% | 19.06% | 3.45% | 17.18% |
Cost of Revenue | 614.34 | 624.25 | 573.98 | 568.5 | 474.23 | 442.6 |
Gross Profit | 756.17 | 750.48 | 733.03 | 676.25 | 571.25 | 568.04 |
Selling, General & Admin | 584.82 | 591.97 | 478.28 | 503.04 | 454.04 | 414.75 |
Research & Development | 59.27 | 55.88 | 54.43 | 52.6 | 47.15 | 43.57 |
Other Operating Expenses | 0.42 | 0.42 | - | - | 112.01 | 1.13 |
Total Operating Expenses | 644.51 | 648.27 | 532.71 | 555.64 | 613.2 | 459.45 |
Operating Income | 111.66 | 102.2 | 200.33 | 120.6 | -41.96 | 108.59 |
Interest Expense | -29.86 | -31.09 | -37.3 | -39.78 | -28.91 | -35.49 |
Total Non-Operating Income (Expense) | -29.86 | -31.09 | -37.3 | -39.78 | -28.91 | -35.49 |
Pretax Income | 81.8 | 71.12 | 163.03 | 80.83 | -70.86 | 73.11 |
Provision for Income Taxes | 26.95 | 24.06 | 30.61 | 16.37 | 9.72 | 10.56 |
Net Income | 54.85 | 47.06 | 132.42 | 64.46 | -80.58 | 62.54 |
Net Income to Common | 54.85 | 47.06 | 132.42 | 64.46 | -80.58 | 62.54 |
Net Income Growth | -53.81% | -64.47% | 105.44% | - | - | 557.16% |
Shares Outstanding (Basic) | 31 | 31 | 31 | 31 | 30 | 29 |
Shares Outstanding (Diluted) | 31 | 31 | 31 | 32 | 30 | 32 |
Shares Change (YoY) | -0.61% | -0.00% | -1.26% | 5.02% | -6.75% | 9.34% |
EPS (Basic) | 1.77 | 1.52 | 4.29 | 2.10 | -2.68 | 2.14 |
EPS (Diluted) | 1.77 | 1.51 | 4.25 | 2.04 | -2.68 | 1.94 |
EPS Growth | -53.42% | -64.47% | 108.33% | - | - | 506.25% |
Shares Outstanding | 30.14 | 30.97 | 30.9 | 30.77 | 30.49 | 29.37 |
Free Cash Flow | 123.71 | 150.88 | 153.88 | 106.32 | 11.58 | 96.9 |
Free Cash Flow Growth | -18.01% | -1.95% | 44.74% | 818.10% | -88.05% | 88.10% |
Free Cash Flow Per Share | 4.00 | 4.84 | 4.94 | 3.37 | 0.39 | 3.01 |
Dividends Per Share | 0.400 | 0.600 | 0.800 | 0.800 | 0.800 | 0.800 |
Dividend Growth | -33.33% | -25.00% | - | - | - | - |
Gross Margin | 55.17% | 54.59% | 56.08% | 54.33% | 54.64% | 56.21% |
Operating Margin | 8.15% | 7.43% | 15.33% | 9.69% | -4.01% | 10.74% |
Profit Margin | 4.00% | 3.42% | 10.13% | 5.18% | -7.71% | 6.19% |
FCF Margin | 9.03% | 10.98% | 11.77% | 8.54% | 1.11% | 9.59% |
EBITDA | 186.53 | 176.49 | 272.18 | 192.48 | 27.56 | 179.33 |
EBITDA Margin | 13.61% | 12.84% | 20.82% | 15.46% | 2.64% | 17.74% |
EBIT | 111.66 | 102.2 | 200.33 | 120.6 | -41.96 | 108.59 |
EBIT Margin | 8.15% | 7.43% | 15.33% | 9.69% | -4.01% | 10.74% |
Effective Tax Rate | 32.95% | 33.83% | 18.77% | 20.25% | -13.72% | 14.45% |